NO20005498D0 - Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse - Google Patents

Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse

Info

Publication number
NO20005498D0
NO20005498D0 NO20005498A NO20005498A NO20005498D0 NO 20005498 D0 NO20005498 D0 NO 20005498D0 NO 20005498 A NO20005498 A NO 20005498A NO 20005498 A NO20005498 A NO 20005498A NO 20005498 D0 NO20005498 D0 NO 20005498D0
Authority
NO
Norway
Prior art keywords
ysulfonyl
naphth
piperazine
pyridyl
benzoyl
Prior art date
Application number
NO20005498A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005498L (no
Inventor
Marianne Ashford
Roger James
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005498L publication Critical patent/NO20005498L/no
Publication of NO20005498D0 publication Critical patent/NO20005498D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20005498A 1998-05-02 2000-11-01 Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse NO20005498D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (2)

Publication Number Publication Date
NO20005498L NO20005498L (no) 2000-11-01
NO20005498D0 true NO20005498D0 (no) 2000-11-01

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005498A NO20005498D0 (no) 1998-05-02 2000-11-01 Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse

Country Status (16)

Country Link
EP (1) EP1084118A1 (ja)
JP (1) JP2002513789A (ja)
KR (1) KR20010043216A (ja)
CN (1) CN1308629A (ja)
AU (1) AU3719699A (ja)
BR (1) BR9910176A (ja)
CA (1) CA2331041A1 (ja)
EE (1) EE200000638A (ja)
GB (1) GB9809350D0 (ja)
HU (1) HUP0102394A3 (ja)
IL (1) IL139405A0 (ja)
NO (1) NO20005498D0 (ja)
PL (1) PL343705A1 (ja)
SK (1) SK16522000A3 (ja)
WO (1) WO1999057112A1 (ja)
ZA (1) ZA200006036B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255733T3 (es) * 1997-09-30 2006-07-01 Daiichi Pharmaceutical Co., Ltd. Derivados sulfonilo.
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
ATE334975T1 (de) * 1997-05-30 2006-08-15 Takeda Pharmaceutical Sulfonamidderivate, ihre herstellung und verwendung
ES2255733T3 (es) * 1997-09-30 2006-07-01 Daiichi Pharmaceutical Co., Ltd. Derivados sulfonilo.

Also Published As

Publication number Publication date
KR20010043216A (ko) 2001-05-25
EE200000638A (et) 2002-04-15
EP1084118A1 (en) 2001-03-21
ZA200006036B (en) 2002-01-25
NO20005498L (no) 2000-11-01
WO1999057112A1 (en) 1999-11-11
HUP0102394A3 (en) 2003-01-28
CN1308629A (zh) 2001-08-15
BR9910176A (pt) 2001-01-09
IL139405A0 (en) 2001-11-25
GB9809350D0 (en) 1998-07-01
PL343705A1 (en) 2001-08-27
HUP0102394A2 (hu) 2001-12-28
SK16522000A3 (sk) 2001-05-10
JP2002513789A (ja) 2002-05-14
AU3719699A (en) 1999-11-23
CA2331041A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
ES8405786A1 (es) Un procedimiento para la preparacion de 1-(4,(4,4-dialquil-2,6-piperidindion-1-1l)butil)piperazinas.
NO924764D0 (no) 4-pyrimidinyl- og pyridinylderivater av indol-3-yl-alkylpiperazin
DE60030338D1 (de) Verwendung von 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazin und deren physiologisch akzeptablen Salzen
DE60125980D1 (de) P38kinase-inhibitoren vom piperidin/piperazin-typ
DE60142613D1 (de) Aryl substituierte pyridinen, pyrimidinen, pyrazinen und triazinen und deren verwendung
FI19991729A (fi) 1-((4-Kloorifenyyli)fenyylimetyyli)-4-((4-metyylifenyyli)sulfonyyli)piperatsiinin enantiomeerit
CH1175401H1 (de) Piperazin Derivate verwendbar als CCR5 Antagonisten
ATE343565T1 (de) Phenyl- und pyridinyl-derivate verwendbar als neurokinin-1-antagonisten
NO20000115L (no) Gastrokinetiske monocykliske benzamidler av 3- eller 4- substituerte 4-(aminometyl)-piperidinderivater
NO984380D0 (no) Nye piperazin og piperidin forbindelser
DK1131308T3 (da) Piperazin- og piperidinderivater
EE200300007A (et) Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid
IS7271A (is) Piperdine og piperazine afleiður 2,4-disubstituted, 3,5-disubstituded and 3,4,5-sumstituted piperadines and piperazines
DE69106388D1 (de) Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate.
ES8402832A1 (es) Un procedimiento para la preparacion de compuestos dotados de propiedades psicotropicas.
DE69610316T2 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
NO20005498D0 (no) Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse
SG127737A1 (en) Piperidine and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
RS49904B (sr) Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida
FI923723A (fi) 4-(4-(4-(-hydroxifenyl)-1-piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat
FR2672286B1 (fr) Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
NO20000665L (no) 2-{3-[4-(2-t-Butyl-6-trifluormetyl-4-pyrimidinyl)-1- piperazinyl]propyltio}-4-pyrimidinol-fumarat
DE60204791D1 (de) Synthese von 4-(piperidyl) (2-pyridyl)methanon-(e)-o-methyloxim und seinen salzen
NO20031698D0 (no) Krystallformer av 1-(6-klor-5-(trifluormetyl)-2- pyridinyl)piperazin-hydroklorid
AU3793478A (en) 4-[4-(2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl-methyl)-1-piperazinyl]-6-methyl pyrimidine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application